Focal dystonia after chemotherapy: A case series

Journal of Neuro-Oncology

Volumn 34, Issue 2, 1997, Pages 163-167

  Brashear, A ^a,b   Siemers, E ^a  

^a INDIANA UNIVERSITY   (United States)

^b University of Hospital   (United States)

Author keywords

Cancer; Chemotherapy; Dystonia; Movement disorder; Neurotoxicity; Parkinsonism

Indexed keywords

DOXORUBICIN; FLUOROURACIL; LEVAMISOLE;

ADULT; ARTICLE; BASAL GANGLION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSTONIA; FEMALE; HUMAN; INVOLUNTARY MOVEMENT; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COLONIC NEOPLASMS; DOXORUBICIN; DYSTONIA; FEMALE; FLUOROURACIL; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0031008863     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005791623733     Document Type: Article

References (20)

1. Marsden CD, Harrison MJG, Bundey S: Natural history of idiopathic torsion dystonia. Adv Neurol 14: 177-186, 1976
2. Weiner WJ, Lang AE , eds. Movement Disorders: A Comprehensive Survey. Futura Publishing Company, New York, 1989
3. Bhatt MH, Obeso JA, Marsden CD: Time course of post-anoxic akinetic-rigid and dystonic syndromes. Neurology 43: 314-317, 1993
4. Lee MS, Rinne JO, Ceballos-Baumann A, Thompson PD, Marsden CD: Dystonia after head trauma. Neurology 44: 1374-1378, 1994
5. Tolosa E, Kulisevsky J: Dopaminergic mechanisms in cranial dystonia. Adv Neurol 49: 433-441, 1988
6. Boranic M, Raci F: A Parkinson-like syndrome as side effect of chemotherapy with vincristine and Adriamycin in a child with acute leukemia. Biomedicine 31: 124-125, 1979
7. Luque FA, Selhorst JB, Petruska P: Case Report: Parkinsonism induced by high-dose cytosine arabinoside. Mov Disord 2: 219-222, 1987
8. Bergevin PR, Patwardhan VC, Weissman J, Lee SM: Neurotoxicity of 5-fluorouracil (letter). Lancet 7903: 410, 1975
9. Ballard PA, Tetrud JW, Langston JW: Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35: 949-956, 1985
10. Tetrud JW, Langston W, Irwin I, Snow B: Parkinsonism caused by petroleum waste ingestion. Neurology 44: 1051-1054, 1994
11. Goodman LS, Gilman AG (eds): Goodman and Gilman's The Pharmacological Bases of Therapeutics. Pergamon Press, Inc, New York, 1990
12. Casey DE: Tardive dyskinesia. West J Med 153: 535-541, 1993
13. Black B, Uhde TW: Acute dystonia and Fluoxetine (letter). J Clin Psychiatry 53: 327, 1992
14. Reccoppa L, Welch WA, Ware MR: Acute dystonia and fluoxetine (letter). J Clin Psychiatry 51: 487, 1990
15. Riehl JL, Brown WJ: Acute cerebellar syndrome secondary to 5-fluorouracil therapy. Neurology 14: 961-967, 1964
16. Phillips PC, Reinhard CS: Antipyrimidine Neurotoxicity: Cytosine Arabinoside and 5-Fluorouracil. In: Rottenberg DA (ed) Neurological Complications of Cancer Treatment. Butterworth-Heinemann, Boston, 1991, pp 87-114
17. Dropcho EJ: Autoimmune central nervous system paraneoplastic disorders mechanism, diagnosis, and therapeutic options. Ann Neurol 37: S102-113, 1995
18. Harris BE, Carpenter JT, Diasio RB: Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. Cancer 68: 499-501, 1991
19. Hook CC, Kimmel DW, Kuols LK, Scheithauer BW, Forsyth PA, Rubin J, Moertel CG, Rodriquez M: Multifocal inflammatory leukoencephalopathy with 5-Fluorouracil and levamisole. Ann Neurol 31: 262-267, 1992
20. Kimmel DW, Wijdickes EF, Rodriquez J: Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology 45: 374-376, 1995